1-8 of 8
Jipan Xie
Close
Sort by
Journal Articles

Cost Effectiveness Analysis of Venetoclax Plus Azacitidine Versus Azacitidine in Newly Diagnosed Adult Patients with Acute Myeloid Leukemia Who Are Ineligible for Intensive Chemotherapy from a United States Payer Perspective

Keith W. Pratz, Xinglei Chai, Jipan Xie, Lei Yin, Xiaoyu Nie, Melissa Montez, Erica Iantuono, Lisa Downs, Esprit Ma
Journal: Blood
Blood (2021) 138 (Supplement 1): 112.
https://doi.org/10.1182/blood-2021-148338
Published: 2021
Journal Articles

Characteristics and Treatment Patterns of Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Who Received ≥3 Lines of Therapies

Jipan Xie, MD PhD, Aozhou Wu, PhD, Laura Liao, MS, Xiaoyan Du, MESc, Ahmed Noman, BA, Yawen Liang, PhD, Joseph Camardo, MD, Lei Chen, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 4–5.
https://doi.org/10.1182/blood-2020-140136
Published: 2020
Journal Articles

Cost-Effectiveness Analysis of Lenalidomide for Maintenance Therapy after Autologous Stem Cell Transplant (ASCT) in Newly Diagnosed Multiple Myeloma (NDMM) Patients: A United States Payer Perspective

Zheng-Yi Zhou, PhD, Kejal Parikh, Xinglei Chai, Ariel Rokito, Chuka Udeze, Jipan Xie, Amit Agarwal
Journal: Blood
Blood (2018) 132 (Supplement 1): 3535.
https://doi.org/10.1182/blood-2018-99-112942
Published: 2018
Journal Articles

Cost-Effectiveness of Midostaurin in the Treatment of Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia in the United States

Eytan M. Stein, MD, Jipan Xie, MD PhD, Emilie Duchesneau, Subrata Bhattacharyya, PhD, Briana Ndife, MPH, Gaetano Bonifacio, MD, George J Joseph, BPharm, MS, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4703.
https://doi.org/10.1182/blood.V130.Suppl_1.4703.4703
Published: 2017
Journal Articles

Racial Disparities in Treatment Patterns and Outcomes Among Patients with Multiple Myeloma: A SEER-Medicare Analysis

Sikander Ailawadhi, Kejal Parikh, BSPharm, MS, Zhou Zhou, MS, Wenxi Tang, MS, Zoe Clancy, MS, PharmD, Claudia Cheung, MS, Zheng-Yi Zhou, PhD, Jipan Xie, MD PhD, Safiya Abouzaid, MPH, PharmD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3426.
https://doi.org/10.1182/blood.V130.Suppl_1.3426.3426
Published: 2017
Journal Articles

Patterns of Prior Treatment and Bleeds Among Patients with Severe Hemophilia a: Impact on Frequency of Dosing with Bay 81-8973 in the Leopold I Trial

Nikki Church, MD MBA, Rajeev Ayyagari, PhD, Jennifer Pocoski, PharmD, Gautam Sajeev, ScD, Sneha S Kelkar, MPH, Ella X Du, MS, Monika Mass-Enriquez, MD, Jipan Xie, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1103.
https://doi.org/10.1182/blood.V126.23.1103.1103
Published: 2015
Journal Articles

Associations Between Joint Damage and Quality of Life Among Patients with Severe Hemophilia a in the 3-Year Spinart Trial

Jennifer Pocoski, PharmD, Peggy L Lin, PhD, Walter Hong, MD, Sneha S Kelkar, MS, MPH, Tianze Jiao, PhD, Ella X Du, MS, Thomas J. Humphries, MD, Jipan Xie, MD PhD
Journal: Blood
Blood (2014) 124 (21): 200.
https://doi.org/10.1182/blood.V124.21.200.200
Published: 2014
Journal Articles

Comparison of Real-World Treatment Patterns and Clinical Outcomes in 18-59 Year-Old Patients with FLT3 Mutated Vs. FLT3 Wild Type Acute Myeloid Leukemia: A Medical Records Review

Jipan Xie, MD PhD, Emily Goldmann, MPH, PhD, Anuja Roy, PhD MBA, Chelsey Yang, BA, Eric Q Wu, PhD, Carole Paley, MD
Journal: Blood
Blood (2014) 124 (21): 5992.
https://doi.org/10.1182/blood.V124.21.5992.5992
Published: 2014